alexa Vilazodone for the Treatment of Paternal Post Natal Dep
ISSN: 2572-0791

Clinical Depression
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Vilazodone for the Treatment of Paternal Post Natal Depression

Hani Raoul Khouzam*

Medical Director, Employee Behavioral Health Dartmouth – Hitchcock Medical Center, Professor of Psychiatry, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA

*Corresponding Author:
Khouzam H
Medical Director
Employee Behavioral Health Dartmouth – Hitchcock Medical Center
Professor of Psychiatry
The Geisel School of Medicine at Dartmouth, Hanover
New Hampshire, USA
Tel: 603.650.4725
E-mail: [email protected]

Received Date: November 02, 2015; Accepted Date: November 03, 2015; Published Date: Novomber 15, 2015

Citation: Khouzam HR (2015) Vilazodone for the Treatment of Paternal Post Natal Depression. Clin Depress 1:104. doi:10.4172/2572-0791.1000104

Copyright: © 2015 Khouzam HR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Maternal postpartum depression is well recognized by clinicians as one of the psychiatric complication of delivery, conversely paternal postpartum depression or paternal postnatal depression which affects up to 10% -14% of new fathers 6 to 12 months after a child birth is rarely recognized and treated. Without proper diagnosis and prompt treatment paternal postnatal depression could lead to dire consequences including, deterioration in paternal mental health, loss of paternal bonding with the newborn child, which has been associated with long term later child psychiatric complications such as conduct disorders, hyperactivity, anxiety, depression, posttraumatic stress disorder and delays in language acquisition. It can also lead to marital conflicts, stressful family interactions and psychiatric disability leading to potential loss of income, and increase medical care costs. Like major depressive disorders the treatment of paternal postnatal depression may require psychopharmacological treatment typically with selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. The purpose of this report is to increase clinicians awareness in recognizing and treating paternal postnatal depression as illustrated in a case of a 30 year-old new father who developed paternal postnatal depression and his progress in response to treatment with the first-of-class serotonin partial agonist reuptake inhibitor antidepressant vilazodone which basic pharmacology is summarized.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version